Featured Research

from universities, journals, and other organizations

Finding points to possible new Parkinson's therapy

Date:
January 28, 2014
Source:
University of Rochester Medical Center
Summary:
A new study shows that, when properly manipulated, a population of support cells found in the brain called astrocytes could provide a new and promising approach to treat Parkinson's disease. These findings, which were made using an animal model of the disease, demonstrate that a single therapy could simultaneously repair the multiple types of neurological damage caused by Parkinson's, providing an overall benefit that has not been achieved in other approaches.

A new study shows that, when properly manipulated, a population of support cells found in the brain called astrocytes could provide a new and promising approach to treat Parkinson's disease. These findings, which were made using an animal model of the disease, demonstrate that a single therapy could simultaneously repair the multiple types of neurological damage caused by Parkinson's, providing an overall benefit that has not been achieved in other approaches.

Related Articles


"One of the central challenges in Parkinson's disease is that many different cell types are damaged, each of which is of potential importance," said Chris Proschel, Ph.D., an assistant professor of Biomedical Genetics at the University of Rochester Medical Center (URMC) and lead author of the study which appears today in the European journal EMBO Molecular Medicine. "However, while we know that the collective loss of these cells contributes to the symptoms of the disease, much of the current research is focused on the recovery of only one cell type."

Parkinson's disease is a progressive neurological disorder which affects an estimated one million Americans. While the condition is associated with the loss of dopaminergic neurons -- cells that produce the important neurotransmitter dopamine -- the disease's impact is actually far more complex and wide-ranging, disrupting basic signaling functions and triggering the destruction of several other types of cells found in the brain.

Consequently, while the preservation and restoration of dopamine producing neurons is critical to slowing or reversing the course of the disease, it is increasingly clear that any successful long-term therapy must both protect the areas of the brain under attack and foster the repair of not only dopaminergic neurons but also the damage that occurs in other cell populations.

"Reversing the disease's impact on the brain is akin to the challenges of fixing a house that is in the process of falling apart," said Proschel. "If you only focus on addressing one aspect of the problem, such as the wiring, but ignore the fact that the roof is leaking and the foundation is crumbling, then you haven't really carried out the necessary repairs and it is only a matter of time before the lights go out again."

Using human brain cells, Proschel and his colleagues isolated a cell population found in the central nervous system called glial precursors. Through the careful manipulation of culture conditions and cell signals, the researchers induced the precursor cells to produce a specific class of astrocytes.

While astrocytes tend to garner far less attention than their more glamorous cousin, the neuron, they nevertheless are critical to maintaining a healthy environment in the brain. On the flip side, scientists are learning that astrocyte dysfunction can contribute to multiple neurological disorders. In both instances, the ability to realize the therapeutic implications of these discoveries has proven to be difficult. The ability of labs such as Proschel's to isolate and identify the unique properties of different kinds of astroctyes, essentially finding the right cell for the right job, offers the possibility of harnessing these cells for new therapies.

The astrocytes used in the study differ from other types of astrocytes present in the mature brain. When implanted into the brains of rats with Parkinson's disease, the new cells acted similar to astrocytes found in the developing brain, which are more effective at building connections between nerves and creating a suitable environment for growth and repair. Consequently, the implanted astrocytes acted like a repair crew, restoring the health and stability of the structure and allowing the brain's nerve cells to recover and resume normal activity.

The researchers were careful to implant the cells only after the rats had developed signs of Parkinson's disease. This delay was important because it mimics how a similar therapy would be used in humans where the neurological damage caused by the disease precedes its visible symptoms.

After transplantation, the researchers observed that not only did dopaminergic neurons recover in the animals, but other nerve cells called interneurons were also rescued. Interneurons play an important role in information processing and movement control, and are also lost in Parkinson's disease. No previous therapies have rescued these cells. Moreover, the therapy restored normal levels of synaptophysin, a protein that is essential for communication between nerve cells. The transplanted rats recovered motor skills to normal levels, essentially reversing the symptoms of the disease.

"The central importance of this work is in revealing a potentially new cell therapy, for which appropriate human cells are in hand, that can be used to restore multiple neuronal populations and to rescue the molecular machinery critical in communication between nerve cells even when cells are transplanted after the damage is already established," said Mark Noble, Ph.D., the director of the URMC Stem Cell and Regenerative Medicine Institute and a co-author of the study. "From what is already known about these cells, it seems likely that they offer a promising approach to a variety of neurological afflictions."


Story Source:

The above story is based on materials provided by University of Rochester Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. C. Proschel, J. L. Stripay, C.-H. Shih, J. C. Munger, M. D. Noble. Delayed transplantation of precursor cell-derived astrocytes provides multiple benefits in a rat model of Parkinsons. EMBO Molecular Medicine, 2014; DOI: 10.1002/emmm.201302878

Cite This Page:

University of Rochester Medical Center. "Finding points to possible new Parkinson's therapy." ScienceDaily. ScienceDaily, 28 January 2014. <www.sciencedaily.com/releases/2014/01/140128184809.htm>.
University of Rochester Medical Center. (2014, January 28). Finding points to possible new Parkinson's therapy. ScienceDaily. Retrieved December 21, 2014 from www.sciencedaily.com/releases/2014/01/140128184809.htm
University of Rochester Medical Center. "Finding points to possible new Parkinson's therapy." ScienceDaily. www.sciencedaily.com/releases/2014/01/140128184809.htm (accessed December 21, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, December 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Tips to Curb Holiday Carbs

The Best Tips to Curb Holiday Carbs

Buzz60 (Dec. 19, 2014) It's hard to resist those delicious but fattening carbs we all crave during the winter months, but there are some ways to stay satisfied without consuming the extra calories. Vanessa Freeman (@VanessaFreeTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Sierra Leone Bikers Spread the Message to Fight Ebola

Sierra Leone Bikers Spread the Message to Fight Ebola

AFP (Dec. 19, 2014) More than 100 motorcyclists hit the road to spread awareness messages about Ebola. Nearly 7,000 people have now died from the virus, almost all of them in west Africa, according to the World Health Organization. Video provided by AFP
Powered by NewsLook.com
Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
The Best Protein-Filled Foods to Energize You for the New Year

The Best Protein-Filled Foods to Energize You for the New Year

Buzz60 (Dec. 19, 2014) The new year is coming and nothing will energize you more for 2015 than protein-filled foods. Fitness and nutrition expert John Basedow (@JohnBasedow) gives his favorite high protein foods that will help you build muscle, lose fat and have endless energy. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins